Caribou Biosciences (CRBU) Current Leases (2022 - 2026)
Caribou Biosciences (CRBU) posted quarterly Current Leases of $1.3 million for Q1 2026, down 32.3% year-over-year from $1.9 million in Q1 2025, and up 7.16% quarter-over-quarter from $1.2 million in Q4 2025.
Caribou Biosciences (CRBU) Current Leases (2022 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Current Leases for 5 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 32.3% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 32.3% YoY), while the FY2025 annual figure was $1.2 million, down 15.78% from the prior year.
- Current Leases improved to $1.3 million in Q1 2026 per CRBU's latest filing, from $1.2 million in the prior quarter.
- Across five years, Current Leases topped out at $2.7 million in Q3 2025 and bottomed at $825000.0 in Q1 2022.
- Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2025 — Current Leases surged 128.1% — and 2026, when it tumbled 32.3%.
- Caribou Biosciences' Current Leases stood at $966000.0 in 2022, then advanced by 24.22% to $1.2 million in 2023, then gained by 18.83% to $1.4 million in 2024, then retreated by 15.78% to $1.2 million in 2025, then climbed by 7.16% to $1.3 million in 2026.
- Business Quant data shows CRBU's Current Leases at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 966,000.00 |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 877,000.00 |
| Mar 31, 2022 | 825,000.00 |